A nurse is reviewing the medication administration record for a client who has cancer and is receiving morphine via a PCA pump. Which of the following prescriptions should the nurse clarify with the provider?

A) Document the administration of the medication: Documentation of medication administration is an essential step in the medication administration process, ensuring accurate recording of the time, dose, route, and client's response to the medication. However, before administering a controlled substance, the nurse should first identify the client using two identifiers to prevent medication errors.

B) Identify the client using two identifiers: This is the correct initial action. Verifying the client's identity using two identifiers, such as name and date of birth, is a crucial safety measure to ensure that the medication is administered to the correct individual. By confirming the client's identity, the nurse helps prevent medication errors and promotes patient safety.

C) Remove the medication from the medication dispensing cabinet: While obtaining the medication from the medication dispensing cabinet is necessary for administration, it should occur after confirming the client's identity. Identifying the client using two identifiers is the priority to ensure accurate medication administration.

D) Compare the amount of medication available to the inventory record: Verifying the amount of medication available against the inventory record is an important step in medication management to maintain adequate stock levels and prevent medication shortages. However, it is not the first action the nurse should take before administering a controlled substance. Confirming the client's identity is the priority to ensure safe medication administration.

A) Increased energy: While increased energy could be a positive outcome of treatment, it is not a specific indicator of the client's response to spironolactone therapy for’cirrhosis.

B) Decreased ascites: This is the correct answer. Spironolactone, a potassium-sparing diuretic, is commonly used to treat ascites in clients with cirrhosis by promoting diuresis and reducing fluid retention in the abdomen. Therefore, a decrease in ascites indicates a positive response to spironolactone therapy.

C) Increased appetite: Increased appetite is not typically a direct response to spironolactone therapy for cirrhosis. It may be influenced by various factors and is not specific to the client's response to the medication.

D) Decrea’ed jaundice: While spironolactone may indirectly help improve liver function, decrease fluid retention, and alleviate symptoms of cirrhosis, it is not primarily used to address jaundice. Other interventions and treatments may be necessary to manage jaundice in clients with liver cirrhosis.